A number of N-alkyl indole or indazole-3-carbonyl analogs, with modified chemical
structures, are distributed throughout the world as synthetic cannabinoids. Like synthetic …

Introduction: The emergence of novel psychoactive substances has changed the
epidemiology of drugs used recreationally throughout Europe and have posed significant …

Synthetic cannabinoid (SC) designer drugs based on indole and indazole scaffolds and
featuring l-valinamide or l-tert-leucinamide side chains are encountered with increasing …

Synthetic cannabinoid (SC) designer drugs featuring bioisosteric fluorine substitution are
identified by forensic chemists and toxicologists with increasing frequency. Although …

We identified two new-type cannabimimetic quinolinyl carboxylates, quinolin-8-yl 1-pentyl-(1
H-indole)-3-carboxylate (QUPIC, 1) and quinolin-8-yl 1-(cyclohexylmethyl)-1 H-indole-3 …

In 2016 the Psychoactive Substances Bill banned trading but not possession of all current
and future novel psychoactive substances (NPS), sometimes incorrectly called “legal highs,” …

URB-754 (6-methyl-2-[(4-methylphenyl) amino]-1-benzoxazin-4-one) was identified as a
new type of designer drug in illegal products. Though many of the synthetic cannabinoids …

Synthetic cannabinoid receptor agonists (SCRAs) have proliferated as new psychoactive
substances (NPS) over the past decade. Relative to other classes of NPS, SCRAs are …

Synthetic cannabinoids are the psychotropic compounds frequently identified as active
components of smoking mixtures easily available via the Internet in several countries. These …

Abstract From November 2013 to May 2014, 19 newly distributed designer drugs were
identified in 104 products in our ongoing survey of illegal products in Japan. The identified …